Netflix is launching a new daily word puzzle game, “TED Tumblewords,” aiming to capture the same magic that Wordle achieved in 2022. With its free access for subscribers and social sharing features, the game could become a hit and further enhance Netflix’s gaming ambitions. The game, in partnership with TED, will be available on both Android and iOS devices.
Viridian Therapeutics announced positive topline data from their THRIVE Phase 3 clinical trial for VRDN-001 (veligrotug), a potential treatment for active thyroid eye disease (TED). The trial met all primary and secondary endpoints, demonstrating veligrotug’s effectiveness in reducing symptoms and improving patient outcomes.
